Lindsay Janka
- A randomized phase 3 study of reslizumab efficacy in relation to blood eosinophil levels in patients with moderate to severe asthmaBy Jonathan Corren, Steven Weinstein, Lindsay Janka, Christopher O'Brien and James ZangrilliJonathan Corren1Division of Allergy and Immunology, David Geffen School of Medicine at UCLA, Los Angeles, CA,Steven Weinstein2Allergy, Asthma, and Immunology, Allergy and Asthma Specialists Medical Group and Research Center, Huntington Beach, CA,Lindsay Janka3Teva Pharmaceuticals, Teva Pharmaceuticals, Frazer, PA,Christopher O'Brien3Teva Pharmaceuticals, Teva Pharmaceuticals, Frazer, PA,James Zangrilli3Teva Pharmaceuticals, Teva Pharmaceuticals, Frazer, PA,
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, includes a companion volume of self-assessment questions and features the ERS Practical Handbooks.